Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with α-interferon

Haematologica

Volumn 87, Issue 1, 2002, Pages 17-22

  Hernández Boluda, Juan Carlos ^a   Carreras, Enric ^a   Cervantes, Francisco ^a   Marín, Pedro ^a   Arellano Rodrigo, Eduardo ^a   Rovira, Montserrat ^a   Solé, Francesc ^a   Lloveras, Elisabet ^a   Espinet, Blanca ^a   Ocejo, Agustín ^a   Montserrat, Emili ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Autografting; Chronic myeloid leukemia; Interferon; Mobilization; rHuG CSF

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CD34 ANTIGEN; HYDROXYUREA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ARTICLE; AUTOTRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CELL ISOLATION; CELL SELECTION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LEUKAPHERESIS; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MALE; METAPHASE CHROMOSOME; MONONUCLEAR CELL; PHILADELPHIA 1 CHROMOSOME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL RESPONSE MODIFIERS; BLOOD CELL COUNT; BLOOD COMPONENT REMOVAL; BONE MARROW PURGING; BUSULFAN; CYTARABINE; FEASIBILITY STUDIES; FEMALE; FILGRASTIM; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; HYDROXYUREA; INTERFERONS; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; LEUKOCYTOSIS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; PAIN; PHILADELPHIA CHROMOSOME; REMISSION INDUCTION; SAFETY; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0036156772     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Chronic myeloid leukemia
2. Autologous transplantation therapy for chronic myelogenous leukemia
3. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML
4. In vitro marrow purging in chronic myelogenous leukemia: Effect of mafosfamide and recombinant granulocyte-macrophage colony-stimulating factor
5. Interferon a-2a compared with conventional chemotherapy for the treatment of chronic myeloid leukemia
6. Interferon a-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia
7. Granulocyte colony-stimulating factor given in addition to interferon-α to mobilize peripheral blood stem cells for autologous transplantation in chronic myeloid leukaemia
8. Collection of Ph-negative progenitor cells with granulocyte-colony stimulating factor in patients with chronic myeloid leukaemia who respond to recombinant a-interferon
9. Collection of Ph-negative progenitor cells from Ph+ CML patients in complete cytogenetic remission after long-term interferon-α therapy
10. Collection of Ph-negative progenitor cells from interferon responsive patients with chronic myeloid leukemia: Effect of granulocyte-colony-stimulating factor mobilization
11. Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-α
12. Mobilization of Philadelphia-negative peripheral blood mononuclear cells in chronic myeloid leukaemia using hydroxyurea and G-CSF (filgrastim)
13. Autologous transplantation with Philadelphia-negative progenitor cells for patients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to a interferon
14. Improved sensitivity of BCR-ABL detection: A triple-probe three-color fluorescence in situ hybridization system
15. Autologous stem cell transplantation in chronic myelogenous leukemia: A retrospective analysis of the European Group for Bone Marrow Transplantation
16. Autologous transplants for chronic myelogenous leukaemia: Results from eight transplant groups
17. Growth characteristics of leukemia and normal hematopoietic cells in Ph1+ chronic myelogenous leukemia in vivo and in vitro and effects of intensive treatment with the L15 protocol
18. Treatment of chronic myeloid leukaemia in first chronic phase with idarubicin and cytarabine: Mobilization of Philadelphia-negative peripheral blood stem cells
19. Autografting with Philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia
20. Interferon a restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired β1 integrin receptor function
21. Growth factor-mediated terminal differentiation of chronic myeloid leukemia
22. Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation